Dec 10, 2017SuspendedNCT03218683: Phase 1/2: Study of AZD5991 Alone or with Venetoclax in Relapsed Hem MalignanciesNCT03218683: Phase 1/2: Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies....